TY  - GEN
AU  - Nauck,M
TI  - Incretin therapies: highlighting common features and differences in the modes of action of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors
SN  - 1463-1326
PY  - 2016///1104
KW  - Blood Glucose
KW  - drug effects
KW  - Diabetes Mellitus, Type 2
KW  - blood
KW  - Dipeptidyl-Peptidase IV Inhibitors
KW  - pharmacology
KW  - Glucagon-Like Peptide-1 Receptor
KW  - therapeutic use
KW  - Humans
KW  - Hypoglycemic Agents
KW  - Incretins
KW  - Insulin
KW  - metabolism
KW  - Insulin Secretion
KW  - Insulin-Secreting Cells
KW  - Glucagon-Like Peptide-1 Receptor Agonists
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
UR  - https://doi.org/10.1111/dom.12591
ER  -